Extended Information:
VETERA™ VEWT + WNV
Boehringer Ingelheim
Encephalomyelitis-West Nile Virus Vaccine
Eastern & Western & Venezuelan, Killed
Virus
Tetanus Toxoid
Indications:
For the vaccination of healthy horses 6 months of
age or older as an aid in the prevention of diseases caused by Eastern,
Western, and Venezuelan Encephalomyelitis, tetanus, and viremia caused
by West Nile Virus. Duration of immunity studies are in progress.
Administration and Dosage:
Shake well before use. Using aseptic technique,
inoculate horses intramuscularly with a 1 mL dose. Administer a second 1
mL dose intramuscularly in 3-4 weeks using a different injection site.
Revaccinate annually and prior to anticipated exposure with a single 1
mL intramuscular dose.
Precautions:
Store at 35-45°F (2-7°C). Protect from freezing. Do
not vaccinate within 21 days before slaughter. Anaphylactoid reactions
may occur following use. Antidote: Epinephrine.
Preservative:
Gentamicin
This product has been tested under laboratory
conditions and shown to meet all Federal standards for safety and
efficacy in normal, healthy, immunocompetent animals. This level of
performance may be affected by conditions such as stress, weather,
nutrition, disease, parasitism, other treatments, individual
idiosyncrasies, or impaired immunological competency. These factors
should be considered by the user when evaluating product performance or
freedom from reactions.
|